Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00470418 · ClinicalTrials.gov registry record · Phase 2
Development of NIC5-15 in the Treatment of Alzheimer's Disease
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT00470418: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT00470418 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00470418, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of NIC5-15in the treatment of Alzheimer's Disease.
Interventions
- DRUG Placebo
- DRUG NIC5-15
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2007-01 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00470418
The ClinicalTrials.gov registry entry for NCT00470418 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00470418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00470418 about?
NCT00470418 is a clinical study titled "Development of NIC5-15 in the Treatment of Alzheimer's Disease". The purpose of this study is to evaluate the safety and efficacy of NIC5-15in the treatment of Alzheimer's Disease.
What is the current status of trial NCT00470418?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2007-01. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00470418?
The interventions under investigation include: Placebo (DRUG), NIC5-15 (DRUG).
Who is sponsoring clinical trial NCT00470418?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.